Clinical Trials Logo
  1. Home
  2. Liver Transplantation
  3. NCT02521584
  4. Details
NCT02521584 Clinical Trial

Ischemia Time and Graft Survival

Liver Transplant Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02521584
Other study ID # Adel/2015
Secondary ID
Status Recruiting
Phase N/A
First received August 9, 2015
Last updated August 11, 2015
Start date January 2015
Est. completion date March 2017

Study information
Verified date August 2015
Source Mansoura University
Contact Adel Hassan, MD
Email Apoadel2004@yahoo.com
Is FDA regulated No
Health authority Egypt:Mansoura university
Study type Observational

Clinical Trial Summary

Study the effect of ischemia time on patient and graft survival.

Description:

Study the effect of cold ischemia and warm ischemia on graft function after one year and patient one year survival.

Recruitment information / eligibility
Status Recruiting
Enrollment 150
Est. completion date March 2017
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender Both
Age group 25 Years to 60 Years
Eligibility Inclusion Criteria:

- recipients of living donor liver transplantation

Exclusion Criteria:

- early mortality

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Locations
Country Name City State
Egypt Mansoura university Mansoura Dakahleya

Sponsors (1)
Lead Sponsor Collaborator
AlRefaey Kandeel

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary one year graft survival one year Yes
See also
  Status Clinical Trial Phase
Completed NCT02798861 - Controlled Attenuation Parameter (CAP) in Liver Allografts
Completed NCT03527238 - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine Phase 2
Completed NCT01696331 - Text Messaging for Adherence in Adolescent Liver Transplant Recipients N/A
Recruiting NCT05051605 - Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
Recruiting NCT05940857 - Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry
Completed NCT01598987 - Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. Phase 3
Active, not recruiting NCT05074160 - OCS Liver Perfusion (OLP) Post-Approval Registry
Completed NCT05087550 - Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation
Recruiting NCT04836923 - LIFT Intervention in Liver Transplant Candidates N/A
Not yet recruiting NCT03666689 - Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation
Not yet recruiting NCT06088758 - Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool N/A
Terminated NCT01230502 - Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation N/A
Completed NCT00171509 - Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients Phase 4
Not yet recruiting NCT06254248 - Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma Phase 2
Recruiting NCT06075745 - Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates Phase 2
Completed NCT02057484 - A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
Active, not recruiting NCT03577431 - Liver Transplantation With Tregs at MGH Phase 1/Phase 2
Recruiting NCT06342557 - Transitional ePRO Diary Liver
Not yet recruiting NCT04265157 - Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant
Recruiting NCT02863250 - Australian and New Zealand Massive Transfusion Registry